跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 196 条关于
“phosphorylated tau217”
全部
196
临床试验
39
药物
11
机构
0
资讯
146
去年
Phase 2 Alzheimer's Trial Reveals Significant Racial Disparities in Patient Screening for Tau-Targeting Therapy
去年
PrecivityAD2 Blood Test Enhances Alzheimer's Diagnosis and Treatment Decisions
去年
Quanterix Receives South Korean Approval for Alzheimer's Biomarker Detection Platform
3个月前
Soccer Heading Linked to Acute Spikes in Neural Damage Biomarkers S100B and p-tau217 in Amateur Players
2个月前
Alzheimer's Biomarker p-tau217 May Identify Women at Higher Dementia Risk from Combined Hormone Therapy
去年
Eli Lilly's Ceperognastat Fails to Meet Cognitive Endpoints in Phase 2 Alzheimer's Trial
去年
Alzheon's ALZ-801 Shows Promise in Reducing Phosphorylated Tau and Enhancing Memory in Early Alzheimer's Disease
9个月前
Home-Based Gamma Brain Stimulation Shows Promise for Early Alzheimer's Disease in Randomized Trial
去年
Spear Bio and Beckman Coulter Receive FDA Breakthrough Device Designations for Alzheimer's Blood Tests
去年
Neurogen Biomarking to Present Validation Data for At-Home Alzheimer's Blood Biomarker Test at AAIC 2025
第 1 页,共 15 页
上一页
下一页